thioctic acid has been researched along with naltrexone in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Konlee, M | 1 |
| Berkson, AJ; Berkson, BM; Rubin, DM | 2 |
| Buhler, L; Icard, P; Lincet, H; Schwartz, L; Steyaert, JM | 1 |
| Berkson, BM; Calvo Riera, F | 1 |
5 other study(ies) available for thioctic acid and naltrexone
| Article | Year |
|---|---|
New treatments for hepatitis B and C [antigen-specific transfer for A, B & C (chisolm biologicals) and thymate].
Topics: Blood Coagulation; Complementary Therapies; Dietary Supplements; Drug Therapy, Combination; Hepatitis B; Hepatitis C; Humans; Naltrexone; Narcotic Antagonists; Plant Extracts; Thioctic Acid; Transfer Factor; Viral Load | 1998 |
The long-term survival of a patient with pancreatic cancer with metastases to the liver after treatment with the intravenous alpha-lipoic acid/low-dose naltrexone protocol.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Humans; Immunohistochemistry; Infusions, Intravenous; Liver Neoplasms; Male; Middle Aged; Naltrexone; Neoplasm Staging; Palliative Care; Pancreatic Neoplasms; Thioctic Acid; Time Factors; Treatment Outcome | 2006 |
Revisiting the ALA/N (alpha-lipoic acid/low-dose naltrexone) protocol for people with metastatic and nonmetastatic pancreatic cancer: a report of 3 new cases.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Fatal Outcome; Female; Humans; Infusions, Intravenous; Liver Neoplasms; Male; Naltrexone; Pancreatic Neoplasms; Thioctic Acid | 2009 |
Metabolic treatment of cancer: intermediate results of a prospective case series.
Topics: Adult; Aged; Citrates; Compassionate Use Trials; Female; Humans; Male; Middle Aged; Naltrexone; Neoplasms; Prospective Studies; Thioctic Acid; Vitamin B Complex | 2014 |
The Long-Term Survival of a Patient With Stage IV Renal Cell Carcinoma Following an Integrative Treatment Approach Including the Intravenous α-Lipoic Acid/Low-Dose Naltrexone Protocol.
Topics: Administration, Intravenous; Cancer Survivors; Carcinoma, Renal Cell; Combined Modality Therapy; Dose-Response Relationship, Drug; Humans; Integrative Oncology; Kidney Neoplasms; Male; Middle Aged; Naltrexone; Neoplasm Staging; Thioctic Acid; Time Factors | 2018 |